Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.
about
Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cellsHormone dependent metastatic salivary gland carcinoma: a case report.High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of originHER2 in solid tumors: more than 10 years under the microscope; where are we now?Systemic therapy in the management of metastatic or advanced salivary gland cancers.Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report.Maintenance therapy with trastuzumab in her2 positive metastatic parotid ductal adenocarcinoma.Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.Somatic mutations in salivary duct carcinoma and potential therapeutic targets.Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.Metastatic HER-2-positive salivary gland carcinoma treated with trastuzumab and a taxane: a series of six patients.Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review.Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
P2860
Q33645792-69147CE3-6F81-40BC-A324-E8E760D67CABQ33954503-1FB0700C-3E7A-4B0C-A635-2B582C5B0C12Q34436470-6C5485D9-F08A-48CF-91D1-9FAE5EF5D524Q34959996-D8AAA0D6-7344-494C-B123-C3E9721F348DQ35211263-226C453B-77D4-44CA-BEA7-57D8F692C091Q38007528-DB229D7B-55AF-4523-A9B0-188CCE692C59Q38114366-6908D409-BC66-4CA1-8092-4456370A5270Q39028775-28C17346-3938-4EA2-ABC2-C436344722F6Q41906973-BB768E57-0667-45AA-B5ED-706F9ADF5389Q42233857-1D4DEA2A-9E20-4778-8597-B6D513BCA57FQ42936492-B535E2E2-1611-446D-8B69-B635DF39102EQ45996599-6A3AFAC4-9254-4066-B69E-81AAF96AB394Q47133482-EB41B93B-DF58-42B5-BB64-B02A84C1D469Q48234912-365295C4-35A5-4249-8852-7493619B04F5Q50675747-D200F4B1-4915-43B5-9A5D-8FED63003522Q51709905-DD214D34-DA45-4930-B55C-AFD387E639B3Q51734012-08230571-2DCD-45BE-B67C-B4F6B338F352Q53253351-A47CA3FD-4B04-495A-B45F-A8838127DA95Q54376069-6685BB39-7F5B-48B3-BAF0-E7E465EF82C3
P2860
Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted therapy with trastuzu ...... report and literature review.
@en
Targeted therapy with trastuzu ...... report and literature review.
@nl
type
label
Targeted therapy with trastuzu ...... report and literature review.
@en
Targeted therapy with trastuzu ...... report and literature review.
@nl
prefLabel
Targeted therapy with trastuzu ...... report and literature review.
@en
Targeted therapy with trastuzu ...... report and literature review.
@nl
P2093
P2860
P1433
P1476
Targeted therapy with trastuzu ...... report and literature review.
@en
P2093
Abraham Kuten
Orit Kaidar-Person
Salem Billan
P2860
P2888
P304
P356
10.1007/S12032-011-9884-1
P577
2011-03-06T00:00:00Z